Detalhe da pesquisa
1.
Albumin-to-alkaline phosphatase ratio as a predictor of tumor recurrence and prognosis in patients with early-stage hepatocellular carcinoma undergoing radiofrequency ablation as initial therapy.
Int J Hyperthermia
; 38(1): 1-10, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33400889
2.
Comparison of transarterial chemoembolization with radiofrequency ablation for unresectable Barcelona Clinic Liver Cancer stage 0/A hepatocellular carcinoma: a propensity score matching.
J Gastroenterol Hepatol
; 31(2): 442-9, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26259976
3.
Transcatheter arterial chemoembolization combined with radiofrequency ablation delays tumor progression and prolongs overall survival in patients with intermediate (BCLC B) hepatocellular carcinoma.
BMC Cancer
; 14: 849, 2014 Nov 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-25409554
4.
Radiofrequency ablation following first-line transarterial chemoembolization for patients with unresectable hepatocellular carcinoma beyond the Milan criteria.
BMC Gastroenterol
; 14: 11, 2014 Jan 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-24410841
5.
Long-term outcomes and prognostic analysis of radiofrequency ablation for small hepatocellular carcinoma: 10-year follow-up in Chinese patients.
Med Oncol
; 32(3): 77, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25698535